Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.34 |
| ▸ | DAO | P14920 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | CGAS | Q8N884 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | NAPRT | Q6XQN6 | 2/20 | 0.32 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.32 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.32 |
| ▸ | CYTH3 | O43739 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28658514 | 0.88 | ALOX15 (0.34) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL8698385 | 0.86 | LMNA (0.39) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL27363729 | 0.85 | LMNA (0.32) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL29954040 | 0.85 | KDM4E (0.37) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL4030743 | 0.85 | LMNA (0.38) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL311179 | 0.83 | KDM4E (0.35) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL9387500 | 0.81 | TDP1 (0.33) | ALOX15KDM4ETSHRACMSDTDP1 | |
| SCHEMBL3706189 | 0.80 | KDM4E (0.42) | KDM4ETSHRTDP1LMNAHCAR2 | |
| SCHEMBL163471 | 0.76 | — | — | |
| SCHEMBL162924 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 685 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| WO-2025238576-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | Nuovo Pignone Tecnologie – S.r.l. (IT) | 2025-11-20 | — | — | WO | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119869460-A | Sorbent compositions, systems, and methods | 通用电气技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-20250109504-A1 | HETEROCYCLIC NON-TRIAZOLE COMPOUNDS AND METHODS FOR INHIBITING CORROSION IN INDUSTRIAL WATER TREATMENT | CHEMTREAT, INC. (US) | 2025-04-03 | — | — | US | claimed |
| WO-2025072626-A1 | HETEROCYCLIC NON-TRIAZOLE COMPOUNDS AND METHODS FOR INHIBITING CORROSION IN INDUSTRIAL WATER TREATMENT | CHEMTREAT, INC. (US) | 2025-04-03 | — | — | WO | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| US-4361560-A | ANTIBIOTIC CEPHALOSPORINS | AJINOMOTO COMPANY INCORPORATED (JP) | 1982-11-30 | — | — | US | claimed |
| EP-0063027-A2 | Process for the preparation of imidazoledicarboxylic acid derivatives of cephalosporins | AJINOMOTO CO., INC. (JP) | 1982-10-20 | — | — | EP | claimed |
| EP-0019067-B1 | 5,10-DIOXO-5,10-DIHYDRODIIMIDAZO(1,5-A,1',5'-D)PYRAZINE-1,6-DICARBOXYLIC ACID AND A PROCESS FOR PRODUCING IMIDAZOLEDICARBOXYLIC ACID AMIDO-DERIVATIVES | AJINOMOTO CO., INC. (JP) | 1982-10-06 | — | — | EP | claimed |
| EP-0060028-A1 | Cephalosporin derivatives and process for their preparation | AJINOMOTO CO., INC. (JP) | 1982-09-15 | — | — | EP | claimed |
| US-4342860-A | AN UNSATUREATED IMIDE IS USED WITH A DI OR POLYISOCYANATE TO FORM A POLYIMIDE POLYMER | RHONE-POULENC INDUSTRIES (FR) | 1982-08-03 | — | — | US | claimed |
| US-4342861-A | AN UNSATURATGED IMIDE AND A DI OR POLYISOCYANATE GO TO MAKE UP A POLYIMIDE POLYMER WHICH ALSO CONTAINS REPEATING AMIDE GROUPS | RHONE-POULENC INDUSTRIES (FR) | 1982-08-03 | — | — | US | claimed |
| US-4297279-A | CHEMICAL INTERMEDIATE FOR MODIFIED A-AMINOPENICILLINS AND -CEPHALOSPORINS | AJINOMOTO CO., INC. (JP) | 1981-10-27 | — | — | US | claimed |
| EP-0026811-A1 | Cephalosporin derivatives | AJINOMOTO CO., INC. (JP) | 1981-04-15 | — | — | EP | claimed |
| EP-0019067-A1 | 5,10-Dioxo-5,10-dihydrodiimidazo(1,5-a,1',5'-d)pyrazine-1,6-dicarboxylic acid and a process for producing imidazoledicarboxylic acid amido-derivatives | AJINOMOTO CO., INC. (JP) | 1980-11-26 | — | — | EP | claimed |
| EP-0000950-A1 | Imidazole derivatives and salts thereof and their synthesis | THE WELLCOME FOUNDATION LIMITED (GB) | 1979-03-07 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | ALOX15 3885/4885KDM4E 421/4885TSHR 1726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.